Syra Health Corp.
SYRA Healthcare Medical Care Facilities
Syra Health Corp.’s revenue for fiscal 2025 (year ended December 2025) was $7.2 million, down 9.47% from fiscal 2024. In the quarter to June 2026, revenue grew 23.0%, EPS grew 477.4% and free cash flow fell 892.7%, each against the same quarter a year earlier.
Follow SYRA
Syra Health Corp. (SYRA) EV/Sales
As of 16 October 2026, Syra Health Corp. (SYRA) trades at a EV/Sales of 1.3×. Over the past ten years it has ranged from 0.0× (April 2025) to 4.0× (February 2024); the current reading is higher than 84% of that period. That is in line with the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.2× | (45.69%) |
| FY2024 | 0.3× | (55.82%) |
| FY2023 | 0.7× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.0× | 421.88% |
| Mar 2026 | 0.2× | 14.30% |
| Dec 2025 | 0.2× | 46.84% |
| Sep 2025 | 0.1× | 20.30% |
| 11 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| CANOQ Cano Health, Inc. compare | 0.0× |
| NIVF NewGenIvf Group Limited compare | n/m |
| BMGL Basel Medical Group Ltd compare | n/m |
| NVOS Novo Integrated Sciences, Inc. compare | 0.0× |
| MODVQ ModivCare Inc. compare | 0.4× |
| RHEP Adcare Health Systems Inc compare | 0.5× |
| BACK IMAC Holdings, Inc. compare | 0.8× |
| SYRA Syra Health Corp. | 1.3× |
| IONM Assure Holdings Corp. compare | 165× |
| Medical Care Facilities industry median | 1.3× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)